pancreas is lower in hyperleptinaemic patients. Consequently, extremely elevated serum leptin may Background. The ob gene product leptin is secreted by fat cells and reflects the content of fat in the body. play a role in reducing glucose-stimulated insulin secretion and glucose intolerance in CRF. Leptin and insulin concentrations as well as body weight are interrelated and a direct correlation has Key words: leptin; plasma insulin; chronic renal failure been found between these concentrations in humans with normal renal function. Markedly elevated serum leptin concentrations have recently been reported in patients with chronic renal failure (CRF ). The aim of Introduction the present study was to investigate the relation between serum leptin and plasma insulin in patients Leptin (16 kD), the product of the adipose-specific ob with advanced CRF.
the present study was to investigate the relation between serum leptin and plasma insulin in patients Leptin (16 kD), the product of the adipose-specific ob with advanced CRF.
gene, regulates food intake and energy expenditure via Methods. Serum leptin, plasma insulin, as well as body the hypothalamus in animals and because of the widefat content (determined with dual-energy X-ray spread distribution of its receptors it may aÂect other absorptiometry) were determined in a cohort of 46 tissues [1 ] . Under normal circumstances, leptin mRNA patients (mean age 54±2 years) with advanced CRF concentrations correlate with the amount of body fat (creatinine clearance 8±1 ml/min).
in rats [2 ] . It has also recently been demonstrated that Results. In 23 CRF patients with plasma insulin below the concentration of serum leptin is closely related to the median value (14 mU/l ), serum leptin concentrathe amount of body fat in humans with [3] or without tions were no higher than in healthy controls (8.0±1.2
[4,5] CRF. Leptin and insulin concentrations, as well vs 8.4±0.9 ng/ml ). However, in CRF patients with as body weight, are interrelated and there is a direct plasma insulin >14 mU/l (n=23) the serum leptin relationship between insulin and leptin concentrations concentrations were much higher (38.2±11.0 ng/ml; in non-uraemic patients [6 ] . Both leptin and insulin P<0.0001). In CRF patients, serum leptin (normalized concentrations increase with body fat mass [7 ] . for the per cent body fat content) correlated significWhereas short-term insulin administration does not antly (r=0.64; P<0.0001) with plasma insulin concenincrease leptin secretion in humans [8] [9] [10] , long-term trations. However, the increase in plasma insulin was insulin infusion ( 72 h) does [8 ] , most probably via a blunted in patients with very high serum leptin concendirect trophic eÂect of insulin on the adipocytes. trations in relation to the per cent body fat content.
Recently, Emilsson et al.
[11] provided evidence of a Conclusions. The present results demonstrate that functional leptin receptor in the pancreas and found serum leptin concentrations are markedly elevated in that leptin overproduction may reduce glucose-CRF patients with higher plasma insulin than in those stimulated insulin secretion. Moreover, Cohen et al. with lower plasma insulin concentrations. This suggests [12] have showed that leptin attenuates some insulinthat insulin resistance and hyperinsulinaemia contribinduced signals in hepatic cell lines. ute to elevated serum leptin concentrations in CRF.
An impairment of glucose metabolism in uraemic The present results also demonstrate that, when circupatients was recognized more than 85 years ago [13] lating serum leptin concentrations are much higher in and impaired peripheral sensitivity to insulin is a wellrelation to the per cent body fat content, no additional recognized feature of uraemia [14] . Alvestrand et al. increase in plasma insulin occurs. This latter observa- [15] have found that an impaired insulin response to tion suggests that the secretion of insulin by the glucose plays a decisive role in the genesis of glucose intolerance in uraemia. The cause of the impaired hyperparathyroidism is associated with impaired insu-Statistical analysis lin secretion in rats with CRF [16 ] . We have recently
The results are given as mean±SEM. The non-parametric shown that, whereas serum leptin is markedly elevated drome, the aim of the present study was to investigate whether serum leptin is related to plasma insulin The mean concentrations of serum leptin in the 46 in CRF. patients with CRF were 23.1±5.9 ng/ml (range 1.5-220 ng/ml ) compared to 8.4±0.9 ng/ml (range 1.2-30 ng/ml ) in the 56 control subjects (P<0.001).
The mean plasma insulin was 16±1 mU/l (median 14 mU/l; range 5-39 mU/l ). The patient material was
Subjects and methods divided into two cohorts, according to their fasting plasma insulin: one with plasma insulin >14 mU/l Patients and controls (high-insulin group; n=23 ) and one with plasma insulin ∏14 mU/l ( low-insulin group; n=23). The serum
In this cross-sectional study, 46 patients ( 33 males and 13 females) with advanced CRF, partly described previously leptin was of a similar magnitude in the controls [ 3] , were investigated. Their creatinine clearance at the time (8.4±0.9 ng/ml ) and the CRF-patients in the lowof examination was 8±1 ml/min (range 2-15 ml/min). Their insulin group (8.0±1.2 ng/ml ) whereas markedly elevmean age was 54±2 years (range 23-69 years) and their ated (P<0.001) leptin concentrations were observed in body mass index ( BMI), defined as kg/m2, was the patient group with high insulin (38.2±11.0 ng/ml ), 24.3±0.8 kg/m2 (range 14.3-37.5 kg/m2). The cause of CRF as seen in (Figure 1 ) . A strong positive correlation was and vitamin B, C and D supplements. None of the patients found between the serum leptin (r=0.62; P<0.0001) were on lipid-lowering drugs. In the eight type 2 diabetic and plasma insulin. We estimated the influence of body patients the mean dose of insulin given was 0.45±0.11 U/kg. fat by calculating the ratio of leptin to the body fat Serum leptin concentrations were also determined in 56 content. A significant correlation was observed healthy controls (mean age 45±2 years; range 23-71 years).
between this ratio and plasma insulin (r=0.64, Their BMI was 23.8±0.4 kg/m2 (range 18.4-30.8 kg/m2).
P<0.0001), as shown in Figure 2 .
After an overnight fast, blood samples were taken for analysis of plasma insulin and serum leptin. Measurements of body composition (dual-energy X-ray absorptiometry), Discussion creatinine clearance, weight, and length were also performed. The study was approved by the Ethics Committee of Karolinska Institute, Stockholm. All patients gave informed In the present study serum leptin and plasma insulin consent to participate in the study.
showed a significant correlation in patients with CRF, confirming results in non-uraemic patients [6 ] . The concentrations of leptin in serum correlate to the body fat content [3] [4] [5] and it has been suggested that leptin Analyses is a sense parameter for adipose tissue. An increased Serum leptin was analysed with a commercially available body fat content is known to be accompanied by radioimmunoassay kit (Linco Research Inc., St Charles, impaired insulin sensitivity [17 ] . Low insulin sensitivity MO, USA). The leptin assay is completely homologous since in turn is normally accompanied by increased insulin the antibody is raised against highly purified human leptin secretion to preserve normoglycaemia [18 ] . Although and both the standard and the tracer are prepared with short-term insulin infusion does not increase serum human leptin. The coeÃcient of variance in the sample was leptin levels [8] [9] [10] , a long-term insulin infusion (72 h) 6%. A specific RIA assay was used to analyse plasma insulin does [8] . Therefore, it has been suggested that chronic-( Pharmacia, Uppsala, Sweden). All subjects had their body ally elevated concentrations of plasma insulin stimulate composition determined with dual-energy X-ray absorptiob gene expression and the leptin secretion by a direct ometry (DXA) (Lunar Corp., Madison, WI, USA) with Lunar software version 3.4. trophic eÂect [8] . We have recently shown that, Table 1 . Gender, BMI, body fat content, plasma insulin, serum leptin and the serum leptin/body fat (%) ratio in CRF patients with plasma insulin ∏14 mU/l and >14 mU/l, respectively Mean±SEM indicated; BMI, body mass index; CRF, chronic renal failure; DXA, dual-energy x-ray absorptiometry; ns, not significant. Fig. 1 . Relationship between the per cent body fat and the serum leptin concentrations in 23 CRF patients with high plasma insulin (r=0.61; P<0.01) and 23 CRF patients with low plasma insulin (r=0.82; P=0.0001), respectively. Fig. 2 . Relationship (r=0.64; P<0.0001) between the serum leptin/body fat (%) ratio and plasma insulin in 38 non-diabetic and eight type-2 diabetic patients with advanced CRF. Note log scale on y-axis.
